Jaffer Zaidi1, Erofili Grapsa, Frank Tanser, Marie-Louise Newell, Till Bärnighausen. 1. aAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, KwaZulu-Natal, South Africa bUniversity College London Institute of Child Health, London, UK cDepartment of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, USA.
Abstract
OBJECTIVES: To investigate HIV prevalence trends in a rural South African community after the scale-up of antiretroviral treatment (ART) in 2004. METHODS: We estimated adult HIV prevalence (ages 15-49 years) using data from a large, longitudinal, population-based HIV surveillance in rural KwaZulu-Natal, South Africa, over the period from 2004 (the year when the public-sector ART scale-up started) to 2011. We control for selection effects due to surveillance nonparticipation using multiple imputation. We further linked the surveillance data to patient records from the local HIV treatment program to estimate ART coverage. RESULTS: ART coverage of all HIV-infected people in this community increased from 0% in 2004 to 31% in 2011. Over the same observation period adult HIV prevalence increased steadily from 21 to 29%. The change in overall HIV prevalence is nearly completely explained by an increase of HIV-infected people receiving ART, and it is largely driven by increases in HIV prevalence in women and men older than 24 years. CONCLUSION: The observed dramatic increase in adult HIV prevalence can most likely be explained by increased survival of HIV-infected people due to ART. Future studies should decompose HIV prevalence trends into HIV incidence and HIV-specific mortality changes to further improve the causal attribution of prevalence increases to treatment success rather than prevention failure.
OBJECTIVES: To investigate HIV prevalence trends in a rural South African community after the scale-up of antiretroviral treatment (ART) in 2004. METHODS: We estimated adult HIV prevalence (ages 15-49 years) using data from a large, longitudinal, population-based HIV surveillance in rural KwaZulu-Natal, South Africa, over the period from 2004 (the year when the public-sector ART scale-up started) to 2011. We control for selection effects due to surveillance nonparticipation using multiple imputation. We further linked the surveillance data to patient records from the local HIV treatment program to estimate ART coverage. RESULTS: ART coverage of all HIV-infectedpeople in this community increased from 0% in 2004 to 31% in 2011. Over the same observation period adult HIV prevalence increased steadily from 21 to 29%. The change in overall HIV prevalence is nearly completely explained by an increase of HIV-infectedpeople receiving ART, and it is largely driven by increases in HIV prevalence in women and men older than 24 years. CONCLUSION: The observed dramatic increase in adult HIV prevalence can most likely be explained by increased survival of HIV-infectedpeople due to ART. Future studies should decompose HIV prevalence trends into HIV incidence and HIV-specific mortality changes to further improve the causal attribution of prevalence increases to treatment success rather than prevention failure.
Authors: Mickey Chopra; Joy E Lawn; David Sanders; Peter Barron; Salim S Abdool Karim; Debbie Bradshaw; Rachel Jewkes; Quarraisha Abdool Karim; Alan J Flisher; Bongani M Mayosi; Stephen M Tollman; Gavin J Churchyard; Hoosen Coovadia Journal: Lancet Date: 2009-08-24 Impact factor: 79.321
Authors: Portia C Mutevedzi; Richard J Lessells; Tom Heller; Till Bärnighausen; Graham S Cooke; Marie-Louise Newell Journal: Bull World Health Organ Date: 2010-05-10 Impact factor: 9.408
Authors: Andrew Boulle; Gilles Van Cutsem; Katherine Hilderbrand; Carol Cragg; Musaed Abrahams; Shaheed Mathee; Nathan Ford; Louise Knight; Meg Osler; Jonny Myers; Eric Goemaere; David Coetzee; Gary Maartens Journal: AIDS Date: 2010-02-20 Impact factor: 4.177
Authors: Abraham J Herbst; Graham S Cooke; Till Bärnighausen; Angelique KanyKany; Frank Tanser; Marie-Louise Newell Journal: Bull World Health Organ Date: 2009-10 Impact factor: 9.408
Authors: Catherine F Houlihan; Ruth M Bland; Portia C Mutevedzi; Richard J Lessells; James Ndirangu; Hilary Thulare; Marie-Louise Newell Journal: Int J Epidemiol Date: 2010-02-12 Impact factor: 7.196
Authors: Frank Tanser; Victoria Hosegood; Till Bärnighausen; Kobus Herbst; Makandwe Nyirenda; William Muhwava; Colin Newell; Johannes Viljoen; Tinofa Mutevedzi; Marie-Louise Newell Journal: Int J Epidemiol Date: 2007-11-12 Impact factor: 7.196
Authors: Jade Fettig; Mahesh Swaminathan; Christopher S Murrill; Jonathan E Kaplan Journal: Infect Dis Clin North Am Date: 2014-09 Impact factor: 5.982
Authors: Alain Vandormael; Tulio de Oliveira; Frank Tanser; Till Bärnighausen; Joshua T Herbeck Journal: J Epidemiol Community Health Date: 2017-11-24 Impact factor: 3.710
Authors: Nadia N Abuelezam; Alethea W McCormick; Thomas Fussell; Abena N Afriyie; Robin Wood; Victor DeGruttola; Kenneth A Freedberg; Marc Lipsitch; George R Seage Journal: Am J Epidemiol Date: 2016-07-13 Impact factor: 4.897
Authors: Richard J Lessells; Graham S Cooke; Nuala McGrath; Mark P Nicol; Marie-Louise Newell; Peter Godfrey-Faussett Journal: Am J Respir Crit Care Med Date: 2017-10-01 Impact factor: 21.405
Authors: Guy Harling; Marie-Louise Newell; Frank Tanser; Ichiro Kawachi; S V Subramanian; Till Bärnighausen Journal: J Acquir Immune Defic Syndr Date: 2014-08-01 Impact factor: 3.731